Instrumental variables have been widely used for estimating the causal effect between exposure and outcome. Conventional estimation methods require complete knowledge about all the instruments' validity; a valid instrument must not have a direct effect on the outcome and not be related to unmeasured confounders. Often, this is impractical as highlighted by Mendelian randomization studies where genetic markers are used as instruments and complete knowledge about instruments' validity is equivalent to complete knowledge about the involved genes' functions. In this paper, * Address for correspondence: Hyunseung Kang, Department of Statistics, The Wharton School, University of Pennsylvania, Jon M. Huntsman Hall, 3730 Walnut Street, Philadelphia, PA 19104-6340, USA. E-mail: khyuns@wharton.upenn.edu. Hyunseung Kang is a Ph.D. student (E-mail: khyuns@wharton.upenn.edu), Anru Zhang is a Ph.D. student (E-mail: anrzhang@wharton.upenn.edu), T. Tony Cai is Dorothy Silberberg Professor of Statistics (E-mail: tcai@wharton.upenn.edu). Dylan S. Small is Associate Professor (E-mail: dsmall@wharton.upenn.edu). The research of Tony Cai and Anru Zhang was supported in part by NSF FRG Grant DMS-0854973, NSF Grant DMS-1208982 and NIH Grant R01 CA127334-05. The research of Hyunseung Kang and Dylan Small was supported in part by NSF Grant SES-1260782 1 arXiv:1401.5755v1 [stat.ME] 22 Jan 2014 we propose a method for estimation of causal effects when this complete knowledge is absent. It is shown that identification and estimation is possible under a weaker requirement that more than 50% of instruments are valid, without precisely knowing which of the 50%+ instruments are valid. Sharp identification limits with invalid instruments are given. A fast penalized 1 estimation method, called sisVIVE, is introduced for estimating the causal effect without knowing which instruments are valid, with theoretical guarantees on its performance. The proposed method is demonstrated on simulated data and a real Mendelian randomization study concerning the effect of body mass index on health-related quality of life index. An R package sisVive is available on CRAN. Supplementary materials for this article are available online.
INTRODUCTION
Instrumental variables (IV) is a popular method for estimating the causal effect of an exposure on an outcome when there is unmeasured confounding. Conventional IV estimation methods require that the instruments are valid, or more specifically, that the instruments are (A1) related to the exposure (A2) have no direct pathway to the outcome and (A3) are not related to unmeasured confounders that affect the exposure and the outcome (see Figure 1 ).
The challenge in IV estimation is to find valid instruments that satisfy these assumptions.
Unfortunately, this is a difficult task, especially in the case of Mendelian randomization (MR). In MR, the goal is to estimate the causal effect of an exposure on an outcome by using genetic markers, specifically single nucleotide polymorphisms (SNPs), as instruments (Wehby et al., 2008) . For example, Timpson et al. (2005) studied the causal effect of C-reactive protein (CRP), the exposure, on various metabolic outcomes, such as body mass index (BMI) and cholesterol biomarkers (e.g. tryglycerides), using four haplotypes constructed from three SNPs (rs1800947, rs1130864, rs1205) as instruments. The instruments have been previously associated with plasma CRP levels, thereby agreeing with (A1). However, agreement with (A2) and (A3) is less certain. As the authors of the study noted, it's plausible that one or more of these genes that contain these SNPs, rs1800947, rs1130864, and rs1205, may have multiple functions, known as pleiotropy. That is, if, in addition to changing CRP levels (the exposure), the gene containing one of these SNPs changed triglyceride levels or BMI (the outcome), the gene would have pleiotropic direct effects on the outcome and (A2) would not hold. Indeed, recent work by Martínez-Calleja et al. (2012) suggested that one of the instruments used, specifically rs1130864, is directly linked to BMI, one of the outcomes, raising doubts about causal estimates based on using this SNP as an instrument.
In fact, pleiotropy and its impact on (A2) is a concern in most MR studies (Little and Khoury, 2003; Ebrahim, 2003, 2004; Thomas and Conti, 2004; Brennan, 2004; Lawlor et al., 2008) . As another example, Katan (1986) , in one of the first discussions of MR, proposed to estimate the causal effect of serum cholesterol level on cancer by using the apolipoprotein E polymorphism (APOE)'s effect on serum cholesterol levels. However, as Smith and Ebrahim (2004) argued, the current knowledge about the APOE gene and its multiple pleiotropic effects on longevity, cholesterol biomarkers, and several others, would invalidate the APOE gene as a valid instrument, specifically due to its violation of (A2) and make an IV analysis based on it biased.
Both examples highlight a fundamental limitation with MR studies. Verifying genetic instruments as valid IVs, especially (A2), requires having complete knowledge of the instruments' genetic function, such as their pleiotropic effects on the outcome. Unfortunately, as both examples highlight, the biological understanding of many genetic markers and the potential pleiotropic effects are incomplete at the time of the study (Solovieff et al., 2013) .
However, in the face of incomplete biological knowledge and possible instrument invalidity, can valid causal estimates be derived?
Previous work in IV estimation in the presence of possibly invalid instruments is limited.
Traditional instrumental variables literature has stated that to estimate the causal effect of a treatment on an outcome when there are unmeasured confounders, one needs to have at least one instrument that one knows is valid (Wooldridge, 2010) . Kolesár et al. (2011) considered the possibility of identifying causal effects when all the instruments are invalid because of direct effects on the outcome and showed that if the direct effects are orthogonal to the instruments' effects on the treatment, then the causal effect can be identified. Kolesár et al. (2011) describes conditions under which this orthogonality is plausible. But, for MR, this stringent structure on the instruments is not particularly plausible as it would mean that the pleiotropic effects of the IVs are orthogonal to the effects of the IVs on the treatment. Gautier and Tsybakov (2011) analyzed instrumental variables regression in the presence of possibly invalid instruments. However, for their procedure to work, one must have a pre-defined set of valid instruments.
Our paper adds to the prior literature as follows. First, we show that it is indeed possible to identify and estimate the causal effect even if we do not know all the instruments' validity.
Specifically, under a weaker condition where the proportion of invalid instruments is strictly less than 50% of the total instruments, we show that identification and consistent estimation is possible. For example, given four possible haplotypes/instruments in the previous example by Timpson et al. (2005) , consistent estimation of the causal effect of CRP on metabolic phenotypes is still possible if no more than one instrument is invalid, without knowing exactly which of the four is invalid. We also show that this 50% boundary is sharp. For example, in the case of Timpson et al. (2005) , if two or more haplotypes do not follow the IV assumptions, no estimation method can consistently estimate the causal effect unless further assumptions are made.
Second, we develop a fast 1 estimation procedure to estimate the causal effect of the exposure on the outcome and select the invalid instruments in the presence of possibly invalid instruments. The procedure has provable theoretical guarantees on estimation performance and is computationally as fast as ordinary least squares. The procedure is implemented and available as an R package sisVIVE, which stands for Some Invalid Some Valid IV Estimator, on CRAN.
Third, we conduct a simulation study that compares our method to two-stage least squares, the most popular estimation procedure in MR and IV estimation. We show that our procedure dominates two stage least squares in every case where the instruments may be invalid. We also conduct a real MR study concerning the effect of BMI on health-related quality of life (HRQL) measures using our new method.
CAUSAL MODEL AND INSTRUMENTAL VARIABLES

Notation
To define a valid instrument, the potential outcomes approach (Neyman, 1923; Rubin, 1974) for instruments laid out in Holland (1988) is used. For each individual i ∈ {1, . . . , n},
∈ R be the potential outcome if the individual were to have exposure d ∈ R and We denote Y = (Y 1 , . . . , Y n ) to be an n-dimensional vector of observed outcomes, D = (D 1 , . . . , D n ) to be an n-dimensional vector of observed exposures, and Z be a n by L matrix of instruments where row i consists of Z i. . LetZ be an n by L + 1 matrix of instruments where the first column consists of a vector of ones, denoted as 1, and the subsequent columns are from Z.
For any vector α ∈ R L , let α j denote the jth element of α. Let α 1 , α 2 , and α ∞ be the usual 1, 2 and ∞-norms, respectively. Also, for any n by L matrix M ∈ R n×L , we denote the (i, j) element of matrix M as M ij , the ith row as M i. , and the jth column as M .j . Let M T be the transpose of M. Let P M be the n by n orthogonal projection matrix onto the column space of M, specifically
has a proper inverse, unless otherwise noted. Let P M ⊥ be the residual projection matrix, specifically P M ⊥ = I − P M where I is an n by n identity matrix.
Definition of Valid Instruments
We formally define a valid set of L instruments as follows (Glymour et al., 2012) .
Assumption (A1) holds if instruments Z i ∈ R L are partially correlated with the exposure.
The strength of this partial correlation is known in the IV literature as the strength of the instruments. Generally speaking, strong instruments are preferred as they provide lowervariance estimates of the causal effect and are less sensitive to bias (Small and Rosenbaum, 2008; Wooldridge, 2010) . The strength of instruments and hence, the validity, of (A1) can be evaluated with observed data.
On the other hand, assumptions (A2) 
A Model for Violation of IV Assumptions
We formalize how violations of assumptions (A2) and (A3) could arise by using the Additive LInear, Constant Effects (ALICE) model inspired by Holland (1988) and analyzed in Small (2007) . Let d , d ∈ R be possible exposures and z , z ∈ R L be possible sets of instruments.
Suppose we have the following model for the outcome
where φ * ∈ R L and β * ∈ R are unknown parameters. The parameter β * represents the causal parameter of interest, the causal effect between the exposure and the outcome if the exposure changed by one unit. On the other hand, φ * represents the direct effect of the genetic marker on the outcome; changing instruments from z to z results in a direct effect on the outcome by (z − z) T φ * . In other words, φ * represents the violation of direct effect described in assumption (A2). Specifically, if instrument j ∈ {1, . . . , L} has φ * j = 0, the jth instrument has a direct effect and (A2) doesn't holds for that jth instrument. In contrast, if φ * = 0, all L instruments do not have any direct effect on the outcome and (A2) holds for all L instruments. Hence, the support of φ * contains those instruments that have direct effects on the outcome and violate (A2), or simply, the invalid instruments. In the context of MR, the support of φ * would contain pleiotropic instruments since these instruments have non-zero direct effects on the outcome (i.e. φ * j = 0).
where π * ∈ R and ψ * ∈ R L are unknown parameters. The parameter π * is the intercept term. The parameter ψ * represents the presence of confounding, or equivalently, a violation of (A3), because it captures the dependence between the observed instruments Z i. and the
for some values of d and z, violating (A3). Also, like φ * in equation (1), the support of ψ * contains instruments that violate assumption (A3); it contains those instruments that are in linkage disequilibrium or in population stratification, as stated in Section 2.2
When we combine equations (1) and (2), we have the observed data model as follows
where α * = φ * + ψ * . The parameter α * combines both the violations of (A2), represented by φ * , and (A3), represented by ψ * , and carries a slightly different interpretation than φ * and ψ * considered separately. For instance, in MR, if the geneticist concludes that there is no confounding (i.e. ψ * = 0) or the only serious concern is pleiotropic effects on the outcome, α * = φ * and α * would have the same meaning as φ * , the effect of violating (A2).
Alternatively, if the geneticist thinks there is no pleiotropy (i.e. φ * = 0), α * = ψ * and α * represents the effect of violating (A3). In the absence of both pleiotropy and other sources of confounding (e.g. linkage disequilibrium and population stratification) φ * = ψ * = 0,
, and all L instruments would satisfy (A2) and (A3). In contrast, if there is reason to believe both pleiotropy and linkage disequilibrium are present, φ * = 0, ψ * = 0, and α * would represent the net additive effect of violating (A2) and (A3). Regardless of the different interpretations of α * , the support of α * contains the instruments that violate IV assumptions, similar to φ * and ψ * . Unfortunately, the support of α * is unknown our model.
In MR, the support of α * being unknown corresponds to not knowing the entire biology of the genetic instruments and their validity. Subsequent sections of our paper will address whether IV estimation is possible without knowing this information.
Finally, in their current forms, the models (1), (2), and (3) for violations of IV assumptions are linear. These models can be easily extended to non-linear models by including appropriate basis transformations of Z i and this extension will be discussed in a future paper. We stick with linear models to concentrate on the main ideas of the paper.
andZ ∈ R n×(L+1) be an n by L + 1 matrix where the first column ofZ is a vector of ones and the subsequent columns are composed of Z. Parameters π * , α * and β
Furthermore, condition (c) is sharp given conditions (a) and (b).
Conditions (a) and (b) are standard conditions for identification in the IV literature.
Condition (a) states that the matrix of instruments plus the intercept vector,Z, is full rank.
Condition (b) states that the instruments are associated with the exposure. In fact, (b) is similar to assumption (A1), that the instruments are relevant to the exposure.
In contrast, condition (c) departs from previous IV and MR work. Specifically, prior literature operated under an additional assumption (along with (a), (b), and (c)) that full information about instruments' validity was given. With this additional assumption, (c) would be replaced by s < L (i.e. at least one instrument is known to be valid), a familiar condition from econonmetric textbooks (Wooldridge, 2010) . Specifically, to use econometrics terminology, s < L combines the "just-identified" case (i.e. s = L−1) and the over-identified case (i.e. s < L − 1). However, as mentioned before, in MR or other IV studies, this full information is unavailable; we don't know which instruments are valid and invalid. Thus, it makes sense that condition (c) needs to be stronger than the traditional condition, s < L.
In particular, as stated in Theorem 1, s < L/2. That is, as long as less than 50% of the total candidate of L instruments are invalid, identification is still possible, even without knowing which of the 50% of instruments are valid and invalid. Furthermore, condition (c) is sharp.
That is, if conditions (a) and (b) hold, but half or more of the L instruments are invalid, then no statistical method can achieve identification or consistent estimation; the bound of s < L/2 cannot be improved. In short, the cost of not knowing which instruments are valid is that the number of invalid instruments, s, is s < L/2, instead of s < L. Figure 2 summarizes the identification result of Theorem 1.
Regions of Identifiability
Number of instruments Number of invalid instruments (s) 
Estimation of the Causal Effect of Exposure on Outcome
To motivate our estimation procedure of the causal effect in the presence of possibly invalid instruments, we first look at the case where we have prior knowledge about exactly which instruments are valid and invalid. In particular, suppose we have the best case where all the instruments are known to be valid and α * = 0 in equation (3). Under this case, a popular estimation procedure to estimate π * and β * is two stage least squares (TSLS) where we (i) regress D onZ and then (ii) regress Y on the predictedD from (i). We can write TSLS as a GMM estimator (Hansen, 1982) under the assumption that the errors i are i.i.d., i.e.
(π,β) = argmin
where PZ is the orthogonal projection matrix onto the columns ofZ. The estimatesπ and β from (4) are not only unique and consistent estimates of π * and β * , respectively, but also asymptotically most efficient estimators under the assumption that all the instruments are valid (Wooldridge, 2010) . However, in our problem, we are unsure about which instruments are valid, something that TSLS assumes.
Despite our lack of knowledge about the instruments' validity, the identification result in Theorem 1, specifically condition (c), provides insight for a new estimation method. An equivalent way of stating condition (c) is that the support of α * contains no more than
-sparse. In essence, (c) requires that α * belong in the sparse regime. 1 penalization is a popular way to deal with estimation of sparse vectors. Thus, a natural way forward is to combine the approaches developed in 1 penalization with that from two stage least squares in (4).
Specifically, for a given λ > 0, letπ λ ,α λ andβ λ be the estimators of π * , α * , and β * , respectively, produced by the following estimation procedure, called some invalid some valid IV estimatior, or sisVIVE,
The procedure is similar to (4), except for the penalty term λ α 1 . In fact, if all the instruments are valid, there would be no need to penalize α since α * = 0 and the proposed procedure in (5) becomes (4). In other words, (5) can be viewed as a generalization of (4).
sisVIVE also bears some resemblance to the traditional 1 penalization procedure, in particular the Lasso (Tibshirani, 1996) . However, there are a few important differences.
First, (5) only penalizes those parameters that we believe are sparse, α * . The estimator (5) does not penalize β * , the causal effect of the exposure on the outcome, because there is no reason to assume sparsity for β * ; the causal effect may be far from zero. In contrast, the traditional Lasso setup penalizes all the parameters in the model. Second, the traditional Lasso only considers regression with all exogenous regressors, which are regressors that are assumed to be independent of the error term or assumed to be fixed. The regressors in our model (3) are not all exogenous; specifically, model (3) contains one random endogenous variable, D i , which is dependent on the error term.
Without loss of generality, we assume that our observed quantities (Y i , D i , Z i. ) are centered to mean zero and the columns of Z are standardized to one. The centering of observed quantities removes the intercept term π and simplifies the estimation procedure in equation (5) to
The scaling of Z allows all L instruments to have identical units so no column of Z gets unfairly penalized by the penalty term simply due to their original units.
Choice of λ
Like many penalization procedures, the choice of the tuning parameter λ affects the performance of the estimation procedure and this is certainly the case with sisVIVE. High values of λ force heavy penalization on α where most elements will be zero while low values of λ have the opposite effect. In practice, cross validation is a popular data-driven method to choose λ. In the same spirit, we propose a K-fold cross validation to choose λ in our procedure (6) 1. Randomly split the n observations (Y i , D i , Z i ) into K pieces so that each kth piece, k ∈ {1, . . . , K} , has roughly n k ≈ n/K observations.
For each λ > 0:
2.1 For each kth piece containing n k observations, computeβ λ andα λ from all the other pieces except the kth piece and evaluate the out-of-sample error, P Z (Y − Zα λ − Dβ λ ) 2 2 /n k from the kth piece.
2.2 Average the out-of-sample error error across K pieces.
3. Choose λ with the lowest average out-of-sample error and denote it as λ cv . Call the corresponding estimate of β * ,β λcv Section 4 discusses the performance ofβ λcv when the tuning parameter is chosen by crossvalidation in various simulation studies.
Estimation Performance
A natural question to ask about a new procedure is its estimation performance. Specifically, how well does sisVIVE estimate the causal effect β * ? The following theorem characterizes the performance of sisVIVE in finite samples.
Theorem 2 (Estimation performance of sisVIVE).
Suppose we have the model specified in equation (3). LetD = P Z D and Z .j 2 = 1 for all j = 1, . . . , L. Define constants µ and ρ
If the number of invalid instruments, s,
the estimateβ λ given by (6) with tuning parameter 3 Z T PD ⊥ ∞ ≤ λ has the following performance guarantee 
which is exactly the same bound as that from sisVIVE. Thus, in theory, sisVIVE will do just as well as TSLS when all the instruments are valid. In Section 4, we extend this observation and study the relationship between TSLS and sisVIVE through various simulation studies.
Fast Numerical Algorithm
In addition to the theoretical guarantees on estimation performance, in practice, a fast, scalable numerical algorithm for estimation is desired, especially for MR where genetic data can be large and there can be many proposed instruments. Theorem 3 outlines a two-step numerical method whose solution is identical to sisVIVE in (6), but is as fast as ordinary least squares.
Theorem 3 (Fast two-step numerical algorithm). Let PD be the projection matrix onto the vectorD and PD ⊥ = I − PD. We propose the two-step algorithm as follows.
Step 1: For a given λ > 0, solve:
Step 2: Useα λ from Step 1 to estimateβ λ bŷ
The solution to the two-step algorithm is identical to the solution to sisVIVE in (6)
In the two-step algorithm, step 1 is the standard Lasso problem with outcome PD ⊥ P Z Y and PD ⊥ Z; remember, sisVIVE in (6) is not the standard Lasso problem as discussed in Section 3.2. Fast algorithms for the Lasso exist, most notably LARS (Efron et al., 2004) . In fact, LARS is able to solveα λ for all values of λ > 0 at the same computational efficiency as ordinary least squares.
Step 2 is also numerically efficient, requiring a simple dot product operation betweenD and Y − Zα λ . Thus, the overall computation burden of the two-step algorithm is in Step 1. But, since
Step 1 can be solved quickly for all λ > 0 by LARS, the proposed two-step algorithm is, practically speaking, as fast as ordinary least squares. Best of all, the estimate from this two-step algorithm is identical to sisVIVE.
SIMULATION STUDY
Section 3.4 provided brief discussion of the relationship between two stage least squares (TSLS), the most popular estimator in IV and MR, and sisVIVE. We extend this analysis by conducting various simulation studies to study estimation performance, |β −β * |, for different methods. Specifically, we compare our proposed procedure with TSLS and ordinary least squares (OLS) under various settings about instrument validity, strength, and endogeneity.
Let there be n = 2000 individuals and L = 10 potential candidate instruments. The
. . , n are generated by
is drawn from a multivariate normal with mean 0 and an identity covariance matrix.
The parameters π * , β * , and τ * are fixed. The parameter α * , which determines the validity of the L instruments is set to α * = (1, . . . , 1, 0, . . . , 0) where the number of 1s (i.e. s) is varied. The simulation settings vary s, γ * , and ρ. The parameter s influences the number of invalid instruments. The parameter γ * influences the strength of the instruments. The parameter ρ influences the endogeneity of D i . For each simulation setting, we repeat the simulation 1000 times. For each repetition, we computeβ λ where λ is chosen by 10-fold cross validation. We also compute estimates from TSLS and OLS. Specifically, we run TSLS as if all the instruments are valid. This is quite common in MR studies where all the instruments are assumed to be valid and the causal estimate is computed using TSLS. When some of the instruments are in fact invalid, TSLS should give biased estimates. We run OLS with Z and D as our regressors and Y as our outcome. We expect OLS to perform poorly when there is substantial endogeneity by D (i.e. the exposure is correlated with unmeasured confounders), since OLS cannot control for endogenous variables. But, OLS should be more efficient than IV methods if there is no endogeneity (Basu and Chan, 2013 (in press ). Figure 3 shows the estimation error under different simulation settings. The plots on the first row show the estimation error when endogeneity is varied (i.e. ρ). The number of invalid instruments is fixed at s = 3 and we consider two sets of instruments, weak and strong. As expected, OLS dominates both TSLS and sisVIVE when the endogeneity is small.
The range of this dominance is dictated by instrument strength; for weak instruments, OLS dominates TSLS and sisVIVE for ρ < 0.25 while for strong instruments, OLS dominates TSLS and sisVIVe for ρ < 0.1. TSLS has a higher error than both OLS and sisVIVE, in part, because it cannot take into account the bias introduced by Z in (3).
The plots on the second row of Figure 3 show the estimation error when the number of invalid instruments (i.e. s) is varied. We fix the endogeneity to be ρ = 0.8 and consider strong and weak instruments. For strong instruments, estimation error for sisVIVE jumps There are ten instruments. Each line represents median estimation error, |β * −β|, after 1000 simulations. The bold line represents our procedure, the thick dotted line represents TSLS, and the thin dotted line represents OLS. For endogeneity plots, we fix the number of invalid instruments to s = 3. For invalid instrument plots, we fix the endogeneity parameter, ρ, to 0.8. For the instrument strength plot, we fix ρ to 0.8 and the number of invalid instruments to 3. The concentration parameter is a popular measure of instrument strength. A high concentration parameter indicates strong instruments and vice versa.
at s = 5, as expected from Theorem 1; it's the 50% boundary where identification cannot be achieved without further knowledge about instruments' validity. For weak instruments, we see that the jump occurs around s = 3. This is smaller than s = 5 and is most likely due to weak instruments. It's also possible that the low s value may be explained by Theorem 2 which suggested a stronger bound on s than Theorem 1. Regardless, for any s and for both weak and strong instruments, sisVIVE performs better than TSLS since sisVIVE takes into account the possible invalid instruments in the set of 10 instruments. Also, sisVIVE performs as well as TSLS when there are no invalid instruments (s = 0), which was expected based on our discussion from Section 3.4.
Finally, the last row of Figure 3 shows the estimation error for different values of the concentration parameter. We fix the endogeneity to be ρ = 0.8 and there are three invalid instruments (s = 3). The concentration parameter is a popular measure for instrument strength; high values of the concentration parameter indicate strong instruments. The concentration parameter is also the population value of the first stage F statistic for the instruments when the treatment is regressed on them; this first stage F statistic is often used to check instrument strength (Stock et al., 2002) . From the plots, we see that, as expected, OLS has a constant error since it is oblivious to instrument strength. In contrast, the estimation errors for sisVIVE and TSLS go down as the instrument strength increases. However, TSLS has a much higher error than sisVIVE because it cannot take into account the three invalid instruments. On the other hand, sisVIVE takes into account the invalid instruments. In fact, for any instrument strength, weak or strong, sisVIVE dominates TSLS and OLS.
Overall, regardless of the degree of endogeneity, instrument strength, and the number of invalid instruments, sisVIVE dominates TSLS in the presence of possibly invalid instruments.
When there are no invalid instruments, sisVIVE is as good as TSLS. When there is at least one, but less than L/2 instruments, sisVIVE performs much better than TSLS. Only when identification is not possible (at s ≥ L/2) does sisVIVE performs just as poorly as TSLS.
But, in contrast to TSLS, sisVIVE does not need to know which instruments are invalid a priori. The promising simulation results suggest that our method, sisVIVE, should be used whenever there is concern about invalid instruments
DATA ANALYSIS
An important question in heath economics is assessing the effect of health-related indicators, such as body mass index (BMI), mobility scores, and medical costs, on utility-based quality of life. Having accurate assessment of such effects drive design and implementation of healthrelated policy decisions that attempt to modify such health-related indicators to maximize individual utility. However, a fundamental difficulty with these studies is controlling for possible confounders that affect the relationship between the indicator and the outcome (Cawley and Meyerhoefer, 2012) . The outcome, utility-based quality of life, encompasses various factors about the individual, making it difficult to control for all possible confounders that may affect these measures. As one example, if the study were to examine the relationship between BMI and a health-based utility measure, diet is a possible confounder. Not only does diet impact BMI, but it also affects one's perceived utility of health. To make matters worse, there's no straightforward way to numerically quantify diet, making it difficult to control for this confounder, even if it were observed.
Mendelian randomization (MR) can be a powerful tool in these studies. MR uses genotypes as instruments to deduce causal relationships between exposure and outcome that are confounded by observed and unobserved variables. Traditional approaches to MR require that all candidate instruments be checked for validity. However, the method we developed allows for possibly invalid instruments amongst the candidate instruments. This feature is attractive since the biology of the genes is not always fully understood, especially when dealing with complex outcomes like utility-based quality of life and its biological association with the candidate genetic instruments.
To demonstrate the power of our method in these studies, we analyze the association between obesity and health utility measures. Previous studies by Trakas et al. (2001) and Sach et al. (2006) To measure quality of life, we use the Health Utility Index Mark 3 (HUI3) which was also used in Trakas et al. (2001) . HUI3 is a composite score of utility between 0 and 1, with 1 indicating highest utility and 0 indicating a utility equivalent to death; negative utility is possible and indicates that the person is alive, but in a state worse than death. To measure obesity, we looked at BMI across several categories of obesity. The categories were based on US National Institute of Health clinical guidelines (National Institute of Health, 1998) and were also used in Trakas et al. (2001) and Sach et al. (2006) . Table 1 would not capture the magnitude of the differences between the obesity classes. To account for this, we define a truncated BMI that takes the minimum of BMI −30 and 0, to not only to indicate obesity, but also to measure its severity. For potential candidate instruments, we use the following single nucleotide polymor-phisms (SNPs) in the WLS that were previously associated with obesity: rs1421085, rs1501299, and rs6265. rs1421085 is in the FTO gene and it has been shown to be strongly associated with obesity (Dina et al., 2007; Price et al., 2008) . rs1501299 (i.e. +276G>T) is in the ADIPOQ gene that encodes adiponectin, a protein encoding for lipid metabolism, and has been associated with obesity (Bouatia-Naji et al., 2006; Yang et al., 2007) . Finally, rs6265
(i.e. Val66Met) is in the brain-derived neurotrophic factor BDNF gene. rs6265 has been shown to not only be associated with BMI (Thorleifsson et al., 2008; Shugart et al., 2009 ), but also neurological and cognitive function (Hwang et al., 2006; Rybakowski et al., 2006) .
Hence, there is some reason to believe that rs6265 may be pleiotropic; rs6265 may impact BMI, the exposure, and affect the outcome through mechanisms other than the exposure.
These mechanisms would violate the IV assumptions of the exclusion restriction (i.e. (A2) in Section 2.2). Table 2 summarizes all the SNPs along with their allelic frequencies. For all the SNPs, we follow an MR study done by Timpson et al. (2005) and assume an additive model. A simple ordinary least squares analysis estimates that an increase in the truncated BMI leads to −0.014 decrease in HUI-3 score. This is consistent with Trakas et al. (2001) which found that obese individuals (i.e. BMI > 30), on average, have lower HUI-3 scores, 0.04 to be exact, than non-obese individuals. If we use two stage least squares, under the operating assumption that all the instruments are valid and ignoring our suspicion that rs6265 may not be a valid IV, the estimated effect is 0.012. Our estimator, sisVIVE, which operates only under the assumption that less than 50% of the instruments are invalid, a reasonable scenario with our three instruments, estimates 0.010 as the causal effect, which is similar to the two stage least squares estimate, but closer to 0. Furthermore, sisVIVE selects rs6265, the SNP that we suspected might not be a valid IV, as an invalid SNP. The results of our method are summarized in Table 3 . 
DISCUSSION
This paper demonstrates that proper estimation of the causal effect is possible without knowledge of all the instruments' validity. Our results show that a weaker knowledge about the proportion of valid instrument is sufficient and we utilize this knowledge to construct sisVIVE that dominates TSLS in almost every aspect. As mentioned throughout the text, future work involves generalizing the model proposed in equation (3) that describe the violations of IV assumptions. The current paper only discussed a simple model to describe violations of instruments' assumptions where the violations occurred in a linear fashion.
However, one can easily generalize the violations to include non-linear terms and other link functions. In addition, we have focused on the applications of our method to Mendelian randomization. In economic applications, it is also common to have multiple candidate instruments and be concerned that some proportion of the instruments are invalid (Murray, 2006) . Our current work demonstrates that instrumental variable estimation is definitely possible even in the presence of possibly invalid instruments.
